Last reviewed · How we verify

NCT02762201: PASI-PAC

Clinical Evaluation of Implant-secured Removable Partial Denture

Terminated NA Last updated 28 August 2019
What this trial tests

NA trial testing PASI in Tooth Loss in 13 participants. Terminated before completion.

Timeline
16 May 2014
Primary endpoint
6 June 2019
6 June 2019

Quick facts

Lead sponsorHospices Civils de Lyon
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment13
Start date16 May 2014
Primary completion6 June 2019
Estimated completion6 June 2019
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Hospices Civils de Lyon — full company profile →

Who can join

18 and older, any sex, with Tooth Loss. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to compare the therapeutic efficiency of implant-secured removable partial denture (PASI) with the therapeutic efficiency of the metalic standard removable partial denture (PAC) in the treatment of intermediate extended-gap (4 adjacent teeth). The therapeutic efficiency will be assessed by the 5 years-prosthetic success rate.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Tooth Loss

Currently open trials in the same condition.

Other Hospices Civils de Lyon trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02762201.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing